Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-04-17
2000-11-28
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424490, 424491, 424493, A61K 4800, A61K 916
Patent
active
061535982
ABSTRACT:
An inorganic particle, to which is bonded a cell binding component and a nucleic acid, is provided for delivery of a nucleic acid to a cell. The disclosed particle acts as a synthetic vector for achieving efficient transfection of associated nucleic acid into a cell.
REFERENCES:
patent: 4452773 (1984-06-01), Molday
Cotten, M. et al. (1992) High-efficiency receptor-mediated delivery of small and large 48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA 89: 6094-6098.
Audesirk, G., Audesirk, T. (1986) Biology: Life on Earth. New York, MacMillan Publishing Company, pp. 66-67.
Wu, G.Y., Wu, C.H. (1988) Receptor-mediated Gene Delivery and Expression in Vivo. The Journal of Biological Chemistry 263(29): 14621-14624.
Walker, P.R. et al. (1989) Effects of Aluminum and Other Cations on the Structure of Brain and Liver Chromatin. Biochemistry 28: 3911-3915.
Filler Aaron Gershon
Lever Andrew Michael Lindsay
Campell Bruce R.
Syngenix Limited
LandOfFree
Synthetic transfection vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic transfection vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic transfection vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725976